CERS News and Press, Cerus Corporation From 05/05/21

Cerus Corporation (CERS) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Matt Notarianni - IR Obi Greenman - President and Chief Executive Officer Vivek Jayaraman - Chief Operating Officer Kevin Green - Chief Financial Officer Carol Moore - Senior Vice President o...

Image source: The Motley Fool. Cerus Corporation (NASDAQ: CERS) Q1 2021 Earnings Call May 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2021. Recent developments and highlights include: First quarter 2021 total revenue of $29.6 million, reflecting a 20% increase over the prior year period. Total revenue w...

Yesterday, the Centers for Medicare & Medicaid Services ("CMS") issued the proposed updates to FY22 payment rates for inpatient hospitals and New Technology Add-on Payments (NTAPs).Stifel analyst Mathew Blackman and the team cite Cerus Corporation ([[CERS]] +0.5%) as a beneficia...

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2021 financial results will be released on Tuesday, May 4, 2021, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will ...

Cerus Corp. reported a record year with strong commercial growth and several pipeline wins. The company expects 2021 to be another record year. The FDA's decided to move the compliance date from April 1st, back to October 1st. Despite the setback, 2021 should be a transformative year ...

Cerus Corporation (Nasdaq: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the Jefferies Virtual Global Plasma Summit on Thurs...

The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in emergency room patients with mild to moderate symptoms of COVID-19.Following a second planned interim analysis of the trial data, an independent d...

Image source: The Motley Fool. Cerus Corporation (NASDAQ: CERS) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript

Cerus Corporation (CERS) Q4 2020 Results Earnings Conference Call February 25, 2021, 4:30 PM ET Company Participants Matt Notarianni - Senior Director, Investor Relations Obi Greenman - President and CEO Vivek Jayaraman - Chief Operating Officer Kevin Green - Chief Financial Officer Carol Moo...